CHICAGO & DUBLIN--(BUSINESS WIRE)--Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ...

People with type I diabetes have to inject themselves multiple times a day with manufactured insulin to maintain healthy levels of the hormone, as their bodies do not naturally produce enough. The ...

If you were sitting around worrying that graphene might not be able to live up to its potential in electrochemical bio-sensing (and that has to be at least half of you), then worry no more: All we ...

Interesting development... aren't there already like, smart glucose monitors that can inject or at least alarm the user that he/she needs insulin? Pretty interesting to make it a component of the ...